GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,948,827 | +18.1% | 99,674 | +41.7% | 0.05% | +23.1% |
| Q2 2023 | $4,188,877 | +5.9% | 70,354 | +0.8% | 0.04% | 0.0% |
| Q1 2023 | $3,954,775 | +102222.8% | 69,823 | +34.2% | 0.04% | -33.9% |
| Q4 2022 | $3,865 | -99.9% | 52,043 | -6.1% | 0.06% | +11.3% |
| Q3 2022 | $3,301,000 | +2.6% | 55,407 | -3.3% | 0.05% | +3.9% |
| Q2 2022 | $3,218,000 | -22.2% | 57,315 | +2.3% | 0.05% | -8.9% |
| Q1 2022 | $4,134,000 | +0.5% | 56,029 | -1.7% | 0.06% | +9.8% |
| Q4 2021 | $4,115,000 | -7.3% | 56,988 | -1.6% | 0.05% | -7.3% |
| Q3 2021 | $4,438,000 | -1.0% | 57,923 | +0.2% | 0.06% | +5.8% |
| Q2 2021 | $4,484,000 | +25.9% | 57,830 | +0.2% | 0.05% | +18.2% |
| Q1 2021 | $3,561,000 | -10.8% | 57,738 | -5.7% | 0.04% | -12.0% |
| Q4 2020 | $3,993,000 | +14.6% | 61,219 | -13.0% | 0.05% | +6.4% |
| Q3 2020 | $3,484,000 | +22.2% | 70,362 | +17.7% | 0.05% | +4.4% |
| Q2 2020 | $2,852,000 | +2.4% | 59,781 | -8.8% | 0.04% | -11.8% |
| Q1 2020 | $2,786,000 | -10.1% | 65,515 | +24.4% | 0.05% | +8.5% |
| Q4 2019 | $3,100,000 | +16.2% | 52,650 | +0.9% | 0.05% | +11.9% |
| Q3 2019 | $2,667,000 | +21.3% | 52,169 | +0.4% | 0.04% | +23.5% |
| Q2 2019 | $2,198,000 | -13.9% | 51,954 | +0.5% | 0.03% | -17.1% |
| Q1 2019 | $2,554,000 | +18.6% | 51,700 | +3.9% | 0.04% | +7.9% |
| Q4 2018 | $2,153,000 | -17.7% | 49,747 | +7.9% | 0.04% | +5.6% |
| Q3 2018 | $2,617,000 | +9.6% | 46,113 | -2.5% | 0.04% | +9.1% |
| Q2 2018 | $2,387,000 | -0.2% | 47,301 | -1.4% | 0.03% | +3.1% |
| Q1 2018 | $2,391,000 | +18.7% | 47,989 | -2.1% | 0.03% | +28.0% |
| Q4 2017 | $2,014,000 | +28.5% | 49,000 | -7.0% | 0.02% | +25.0% |
| Q3 2017 | $1,567,000 | -10.4% | 52,711 | -0.0% | 0.02% | -13.0% |
| Q2 2017 | $1,748,000 | +13.3% | 52,716 | +1.2% | 0.02% | +15.0% |
| Q1 2017 | $1,543,000 | +113.4% | 52,077 | +78.6% | 0.02% | +100.0% |
| Q4 2016 | $723,000 | – | 29,160 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |